Epirus: Corporate Overview (Epirus Biopharmaceuticals) - Apr 9, 2016 - Anticipated global regulatory filings in H2 2017; Anticipated filings in South East Asia and Latin America in 2016
Anticipated non-US regulatory • Anticipated regulatory • Biosimilar
|